LETTERS TO THE EDITOR
Desmopressin for bedwetting SIR,-The article by Evans and Meadow cast further light on the ongoing controversy over the causes of nocturnal enuresis in children.' While some stress the importance of small bladder capacity2 and others the importance of nocturnal polyuria caused by deficient arginine vasopressin (AVP) secretion,3 pmany take the compromise of both factors playing their part.4 In this paper, enuretics responsive to desmopressin had higher nocturnal volumes (345 ml) and lower nocturnal urinary AVP concentrations (0 9) compared with nonresponders (265 and 2-8 respectively). While these differences were insignificant for the small numbers of children involved (eight and 10 respectively) the authors rightly point out that there did appear to be 'a trend towards desmopressin responsive enuretics having lower AVP concentrations and larger volumes of dilute urine at night'. It could well be that significant differences are found with larger numbers of children. It was also interesting that the age of desmopressin responders who appeared to produce more dilute urine was 12 compared with only 9 in the others. This supports our own feeling that the cause of nocturnal enuresis is more likely to be lack of nocturnal AVP secretion in older children and adults and smaller function bladder capacity in those younger. A lot of the work identifying nocturnal enuretics who are AVP deficient was done on older children and adults. Drs Robson and Leung find that desmopressin is most efficacious in children with primary nocturnal enuresis without diurnal symptoms or adverse behavioural or social circumstances. It is likely that most treatments for enuresis would be more effective in such a groupv of children. Their observation that children who have consistently rather than intermittently responded better is interesting and contrasts with our experience that children who wet the bed every night responded extremely poorly to desmopressin. In our experience on an unselected group of children attending a local enuresis clinic and in other authors' experience2 3 desmopressin results in a minority of children becoming dry while on treatment and even fewer remaining dry when treatment is withdrawn.
turnal enuresis with a vasopressin analogue. be changed in those countries in which BCG is given to newborn infants, and that the vaccine be given at the end of the third month instead. I would be concerned that the uptake and consequent coverage of vaccination at 3 months of age will be considerably lower than when given in the neonatal period when the babies are in effect a 'captive' population. In the study reported; at the end of the first year 7% of those immunised in the neonatal period did not have a BCG scar as against 0-6% of those imitunised at 3 months.' I would suggest that even in this country, if BCG was planned to be given at 3 months the number of children not immunised would far exceed 7%, and that as a result although the immunisation itself was more effective, the protection from tuberculosis itself will be less powerful. We do not agree that the number of children coming for vaccination will be fewer at the third month. As more than half of deliveries are not performed at maternity hospitals in developing countries, to reach the newborn for BCG vaccination will be more difficult in those countries. Instead every developing country has a vaccination programme (diphtheria, pertussis, tetanus, and polio) for children, starting in the second
